EPISODE · May 4, 2026 · 1 MIN
Episode 15 | 2026/05/04
from ENT Update
本集探討:頭頸部癌症免疫治療 引用文獻: 1. Chang YC et al. Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory HNSCC. Research Square 2026. DOI: 10.21203/rs.3.rs-9000074/v1 2. He R et al. TMEM92 drives EMT-associated invasiveness and immune suppression in HNSCC. Scientific Reports 2026. DOI: 10.1038/s41598-026-49694-7 3. Chen Y et al. Clinical Significance of Biomarkers in Oropharyngeal SCC. Cancer Reports 2026. DOI: 10.1002/cnr2.70539 4. Trabolsi A et al. Transferrin Receptor Overexpression in Solid Tumors. Cancers 2026. DOI: 10.3390/cancers18091402 5. Innovative biomaterial solutions for enhancing tumor immunotherapy. Immunologic Research 2026. DOI: 10.1007/s12026-026-09762-6 6. Association between antibiotic use and immunotherapy efficacy in ESCC. Int J Clinical Oncology 2026. DOI: 10.1007/s10147-026-03036-9 「ENT Update」— 每週專業耳鼻喉頭頸外科深度對談
What this episode covers
本集探討:頭頸部癌症免疫治療 引用文獻: 1. Chang YC et al. Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory HNSCC. Research Square 2026. DOI: 10.21203/rs.3.rs-9000074/v1 2. He R et al. TMEM92 drives EMT-associated invasiveness and immune suppression in HNSCC. Scientific Reports 2026. DOI: 10.1038/s41598-026-49694-7 3. Chen Y et al. Clinical Significance of Biomarkers in Oropharyngeal SCC. Cancer Reports 2026. DOI: 10.1002/cnr2.70539 4. Trabolsi A et al. Transferrin Receptor Overexpression in Solid Tumors. Cancers 2026. DOI: 10.3390/cancers18091402 5. Innovative biomaterial solutions for enhancing tumor immunotherapy. Immunologic Research 2026. DOI: 10.1007/s12026-026-09762-6 6. Association between antibiotic use and immunotherapy efficacy in ESCC. Int J Clinical Oncology 2026. DOI: 10.1007/s10147-026-03036-9 「ENT Update」— 每週專業耳鼻喉頭頸外科深度對談
NOW PLAYING
Episode 15 | 2026/05/04
No transcript for this episode yet
Similar Episodes
Apr 10, 2026 ·42m
Mar 28, 2026 ·31m
Mar 13, 2026 ·30m
Mar 1, 2026 ·27m
Feb 28, 2026 ·35m